LAS VEGAS--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the immediate availability of a new version (2.0) of the company’s Clinical Trials Signal Detection (CTSD™) system. Briefly, the CTSD system enables clinical safety and medical monitoring staff to:
